)
Edge14 Aug 2026
Deutsche Qualität: The Story of Birkenstock
From an 18th-century German shoemaker to a global footwear brand, how Birkenstock turned an orthopedic insole into the world's most popular sandal.
Shenzhen New Industries Biomedical Engineering
Shenzhen New Industries Biomedical Engineering (300832) investor relations material
Shenzhen New Industries Biomedical Engineering Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2026 earnings summary13 Aug, 2026
Executive summary
Achieved revenue of ¥2.42 billion, up 10.78% year-over-year, and net profit attributable to shareholders of ¥867.71 million, up 12.53%.
Domestic business showed recovery with main business revenue up 7.52% and reagent sales up 12.08% year-over-year.
Overseas business revenue grew 15.17%, with reagent sales up 32.20% and high-end equipment sales strong.
Continued innovation in small molecule sandwich assay technology, with related reagent revenue up 84.79%.
Financial highlights
Operating income: ¥2.42 billion, up 10.78% year-over-year.
Net profit attributable to shareholders: ¥867.71 million, up 12.53% year-over-year.
Operating cash flow: ¥901.17 million, up 95.29% year-over-year.
Basic and diluted EPS: ¥1.1057, up 12.67% year-over-year.
Gross margin: 71.09%, up 2.45 percentage points year-over-year.
Outlook and guidance
Will continue to focus on high-value reagents and expand market share in high-end medical terminals.
Plans to deepen R&D in small molecule sandwich assay and automation platforms.
Expects continued growth in overseas markets through regional and localized operations.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Shenzhen New Industries Biomedical Engineering
- 2025 revenue rose 0.91% to ¥4.58B, with net profit down 11.39% amid strong overseas growth.300832
Q4 2025 - Q1 saw modest revenue and profit growth, strong cash flow, and robust overseas reagent sales.300832Q1 2026
- Revenue up 3.28% in Q3 2025, but net profit down 9.72% as domestic sales declined.300832Q3 2025
- Revenue up 10.12% and net profit up 2.65%, but cash flow dropped sharply on ERP transition.300832Q1 2025
- H1 2025 revenue fell 1.18% to ¥2.18B, net profit down 14.62%, overseas sales up 19.57%.300832Q2 2025
- Q3 revenue and profit rose double digits year-over-year, driven by strong product and market growth.300832Q3 2024
- Net profit surged 20.42% year-over-year on robust sales and margin gains.300832Q2 2024
- Double-digit revenue and profit growth, led by robust overseas expansion and innovation.300832Q4 2024
Next Shenzhen New Industries Biomedical Engineering earnings date
Q3 202630 Oct, 2026
Shenzhen New Industries Biomedical Engineering
Next Shenzhen New Industries Biomedical Engineering earnings date
Q3 202630 Oct, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage